Michal Jarzab

Michał Jarzab received the M.D. and Ph.D. degrees. He graduated from Silesian Medical University, in 2001. He holds a position of the Head of the Center of Diagnostics and Therapy of Breast Cancer (Breast Unit), Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice, Poland. His Ph.D. thesis was devoted to the expression of membrane iodine transporters in breast cancer. Previously, he was appointed at the Department of Tumor Biology, the Center of Translational Research, the Department of Clinical and Experimental Oncology. Since 2011, he has been with the IIIrd Department of Radiotherapy and Chemotherapy. He is also a Board-Approved Specialist in clinical oncology, was involved as a clinical investigator in numerous clinical trials. He is the author or a coauthor of more than 60 original publications, with Hirsch index 16. Since 2001, he has been involved in the development and research activity of one of the first Polish laboratory implementing methods of functional genomics into translation oncology. His research interests include translational genomics of cancer, basic research with the use of transcriptomic techniques and clinical usefulness of classic and molecular predictive factors. He is a coauthor of Polish diagnostic and therapeutic guidelines in oncology, a member of multiple societies, including the American Association of Clinical Oncology, the European Society of Medical Oncology, and the European Society for Radiotherapy and Oncology. He is a member of Board of the Polish Society of Clinical Oncology and the National Societies Committee of European Society of Medical Oncology.